Literature DB >> 6135599

Growth hormone secretion by cultured rat anterior pituitary cells. Effects of culture conditions and dexamethasone.

R Oosterom, T Verleun, J Zuiderwijk, S W Lamberts.   

Abstract

Optimal conditions were sought for the study of GH secretion by cultured normal pituitary cells. Dispersed rat pituitary cells were cultured for 1 week in four different media supplemented with 10% fetal calf serum. Minimal essential medium resulted in high GH content and secretion during a 4-h incubation period, whereas GH secretion was lower (P less than 0.05) for cells cultured in medium 199, Ham's F-10, and RPMI-1640. GH secretion/24 h declined gradually with time. After 2 weeks in culture hormone secretion amounted to 30% of secretion on day 1, but after 3 weeks GH secretion was still measurable. GH recovery during the 3-weeks culture period was more than 600% of the amount initially plated. GH secretion was positively correlated with the bicarbonate concentration between 0.85 and 2.2 g/liter NaHCO3. When pituitary cells were cultured in concentrations varying from 0.5 X 10(5) to 10 X 10(5) cells per dish, GH secretion and content per cell were constant, suggesting that no direct autofeedback occurred in cultures with high cell densities and thus high medium GH. Dexamethasone stimulated GH secretion and content in a dose-dependent way (0.1 nM-10 microM). The stimulatory effect of 100 nM dexamethasone occurred within 24-48 h. After 7 days of treatment with 100 nM dexamethasone, GH secretion had increased to 190% and GH content to 230% of control. In contrast to the effects on GH, dexamethasone suppressed PRL secretion in a dose-dependent way, but this effect was seen only after 7 days of treatment and not after 4 days of treatment. Cycloheximide and actinomycin D prevented the stimulatory effect of dexamethasone on GH secretion. However, 24 h after cessation of cycloheximide treatment GH secretion was stimulated by dexamethasone. Four days of treatment with 100 nM dexamethasone did not affect the GH response to somatostatin, prostaglandin E1, and theophylline, nor the PRL response to dopamine, TRH, and theophylline. Thus, culture conditions may affect GH production, and dexamethasone can be used to culture somatotrophs for longer periods with steady GH production and normal responsiveness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135599     DOI: 10.1210/endo-113-2-735

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Glucocorticoid regulation of a phenobarbital-inducible cytochrome P-450 gene: the presence of a functional glucocorticoid response element in the 5'-flanking region of the CYP2B2 gene.

Authors:  A K Jaiswal; T Haaparanta; P V Luc; J Schembri; M Adesnik
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

2.  ACTH 1-17 stimulates GH pituitary secretion in humans.

Authors:  G Valenti; A Banchini; L Denti; R Polotti; G P Ceda
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

Review 3.  Glucocorticoids and the regulation of growth hormone secretion.

Authors:  Gherardo Mazziotti; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

4.  A Serum-Free System for Primary Cultures of Human Pituitary Adenomas.

Authors:  Eleni Thodou; Lily Ramyar; Arthur I. Cohen; William Singer; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

5.  Perifusion model system to culture bovine hypothalamic slices in series with dispersed anterior pituitary cells.

Authors:  H A Hassan; R A Merkel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-07       Impact factor: 2.416

6.  Deleterious effects of fungizone on growth hormone and prolactin secretion by cultured GH3 cells.

Authors:  C A Lapp; J M Tyler; M E Stachura; Y S Lee
Journal:  In Vitro Cell Dev Biol       Date:  1987-12

7.  Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.

Authors:  W A Breeman; L J Hofland; W H Bakker; M van der Pluijm; P M van Koetsveld; M de Jong; B Setyono-Han; D J Kwekkeboom; T J Visser; S W Lamberts
Journal:  Eur J Nucl Med       Date:  1993-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.